Ad is loading...
CLDX
Price
$23.55
Change
-$2.19 (-8.51%)
Updated
Nov 15 closing price
106 days until earnings call
MIST
Price
$1.70
Change
-$0.11 (-6.08%)
Updated
Nov 15 closing price
135 days until earnings call
Ad is loading...

CLDX vs MIST

Header iconCLDX vs MIST Comparison
Open Charts CLDX vs MISTBanner chart's image
Celldex Therapeutics
Price$23.55
Change-$2.19 (-8.51%)
Volume$1.25M
CapitalizationN/A
Milestone Pharmaceuticals
Price$1.70
Change-$0.11 (-6.08%)
Volume$436.08K
CapitalizationN/A
CLDX vs MIST Comparison Chart
Loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MIST
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CLDX vs. MIST commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a Sell and MIST is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (CLDX: $23.55 vs. MIST: $1.70)
Brand notoriety: CLDX and MIST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 100% vs. MIST: 156%
Market capitalization -- CLDX: $1.56B vs. MIST: $90.56M
CLDX [@Biotechnology] is valued at $1.56B. MIST’s [@Biotechnology] market capitalization is $90.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileMIST’s FA Score has 0 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • MIST’s FA Score: 0 green, 5 red.
According to our system of comparison, MIST is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 5 TA indicator(s) are bullish while MIST’s TA Score has 6 bullish TA indicator(s).

  • CLDX’s TA Score: 5 bullish, 3 bearish.
  • MIST’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both CLDX and MIST are a good buy in the short-term.

Price Growth

CLDX (@Biotechnology) experienced а -10.18% price change this week, while MIST (@Biotechnology) price change was -14.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

CLDX is expected to report earnings on Mar 03, 2025.

MIST is expected to report earnings on Apr 01, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($1.56B) has a higher market cap than MIST($90.6M). MIST YTD gains are higher at: 1.796 vs. CLDX (-40.620). MIST has higher annual earnings (EBITDA): -44.85M vs. CLDX (-160.19M). CLDX has more cash in the bank: 802M vs. MIST (83.3M). CLDX has less debt than MIST: CLDX (2.39M) vs MIST (53.3M). CLDX has higher revenues than MIST: CLDX (8.3M) vs MIST (0).
CLDXMISTCLDX / MIST
Capitalization1.56B90.6M1,724%
EBITDA-160.19M-44.85M357%
Gain YTD-40.6201.796-2,261%
P/E RatioN/AN/A-
Revenue8.3M0-
Total Cash802M83.3M963%
Total Debt2.39M53.3M4%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
50
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDXMIST
RSI
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 5 days ago
81%
View a ticker or compare two or three
Ad is loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MIST
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLPMX5.040.06
+1.20%
Invesco SteelPath MLP Alpha Plus C
CMIEX12.25-0.05
-0.41%
Multi-Manager Intl Eq Strats Instl
AFJAX18.64-0.09
-0.48%
Virtus NFJ International Value A
MINIX43.47-0.24
-0.55%
MFS International Intrinsic Value I
DSMFX14.87-0.19
-1.26%
Destinations Small-Mid Cap Equity I

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with KRYS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-8.51%
KRYS - CLDX
46%
Loosely correlated
-3.75%
AXON - CLDX
43%
Loosely correlated
-0.86%
NTLA - CLDX
40%
Loosely correlated
-7.61%
BEAM - CLDX
38%
Loosely correlated
-8.59%
SRPT - CLDX
38%
Loosely correlated
-4.19%
More

MIST and

Correlation & Price change

A.I.dvisor tells us that MIST and IVEVF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIST and IVEVF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIST
1D Price
Change %
MIST100%
-6.08%
IVEVF - MIST
28%
Poorly correlated
N/A
NERV - MIST
27%
Poorly correlated
-5.17%
CLDX - MIST
27%
Poorly correlated
-8.51%
KRYS - MIST
27%
Poorly correlated
-3.75%
ATRA - MIST
27%
Poorly correlated
-6.03%
More